There was a marked increase in the prevalence of targeted therapy among patients with chronic lymphocytic leukemia (CLL), ...

A predictive model using plasma proteins as biomarkers predicted hepatocellular carcinoma development more accurately than a ...

Although histological transformation to diffuse large B-cell lymphoma (DLBCL) remains a common complication of follicular ...

A recent meta-analysis that assessed prescribed exercise in managing multiple sclerosis (MS) detailed the benefits of ...

Payer coverage of biosimilars is always shifting as new ones come to market, explained Tasmina Hydery, PharmD, MBA, BCGP, ...

In a session during the final full day of conference activity at AXS24, experts from CVS Health and Surescripts emphasized ...

Data from the study showed that exa-cel prevented vaso-occlusive crises in all but 1 of the 30 evaluable patients for at ...

William R. Short, MD, MPH, of the University of Pennsylvania, discusses how a label update for bictegravir can help provide ...

While the novel payment models for expensive cell and gene therapies have been effective, they need to continue evolving, ...

A new definition of rectal cancer in the Netherlands prompted reclassification of cancer as sigmoid tumors, which could lead ...

The health-system specialty pharmacy has the unique ability to coordinate better with the provider and take a team approach ...

Approximately 65% of workers are covered by self-funded employer benefit plans, according to new data from ICON plc.